The FNIH Celebrates 25 Years of Science Leading the Way

As part of our 25th Anniversary, we mark this important milestone with a review of the progress we have made in shaping the course of biomedical science and human health. We have catalyzed innovation and discovery by implementing collaborations and programs to answer the toughest scientific questions. Our initiatives have sped the development of new diagnostics, therapies and cures. Through education, awards and other projects, we have helped cultivate global thought leadership, propel scientific careers and deliver high-quality patient care. At every step of the way, science has served as our beacon.

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Partnership:

A landmark public-private partnership launched in response to the COVID-19 pandemic and coordinated by the FNIH to speed development of urgently needed vaccine and treatment options.

Read More

Accelerating Medicines Partnership for Schizophrenia (AMP SCZ):

The newest addition to AMP, pioneering the identification of early indicators of schizophrenia to identify people at risk and develop better treatments.

Read More

Deeda Blair Research Initiative for Disorders of the Brain:

An initiative to drive innovation in mental health research by supporting the taking of risks and creative—even disruptive—ideas to accelerate diagnoses and treatments for severe mental illness. It seeks to foster transformative change by helping uncover new targets and approaches for therapy.

Read More

GeneConvene Global Collaborative:

An initiative to advance the safe, responsible exploration of genetic biocontrol technologies for public health—including gene drive approaches for malaria control—that have the potential to save many lives.

Read More